Search results for "interval"

showing 10 items of 1703 documents

COVID-19 Vaccine: A Survey of Hesitancy in Patients with Celiac Disease

2021

(1) Background: COVID-19 vaccination campaigns offer the best hope of controlling the pandemic. However, the fast production of COVID-19 vaccines has caused concern among the general public regarding their safety and efficacy. In particular, patients with chronic illnesses, such as celiac disease (CD), may be more fearful. Information on vaccine hesitancy plays a pivotal role in the development of an efficient vaccination campaign. In our study, we aimed to evaluate COVID-19 vaccine hesitancy among Italian CD patients. (2) Methods: an anonymous questionnaire was sent to CD patients followed at our tertiary referral center for CD in Milan, Italy. Patients were defined as willing, hesitant an…

medicine.medical_specialtyCoronavirus disease 2019 (COVID-19)ImmunologyCOVID-19 vaccinesDiseaseArticle03 medical and health sciences0302 clinical medicineInternal medicineDrug DiscoveryPandemicMedicinePharmacology (medical)Adverse effectPharmacologyResponse rate (survey)business.industryRCOVID-19Odds ratiovaccinesConfidence intervalVaccinationInfectious Diseases030220 oncology & carcinogenesisMedicinevaccine hesitancy030211 gastroenterology & hepatologybusinessCOVID-19 vaccineceliac diseaseVaccines
researchProduct

Decreased Esophageal Sensitivity to Acid in Morbidly Obese Patients: A Cause for Concern?

2017

Background/Aims: To evaluate esophageal sensitivity to acid between morbidly obese (MO) patients and non-MO controls with abnormal esophageal acid exposure. Methods: We conducted a cross-sectional study of 58 patients: 30 MO (cases) and 28 non-MO (controls). Esophageal symptoms and esophageal sensitivity to 0.1 M hydrochloric acid solution (Bernstein test) were compared between MO and non- MO patients with a prior diagnosis of abnormal esophageal acid exposure. Results: MO patients were less symptomatic than non-MO controls (14% vs 96%; odds ratio [OR], 0.006; 95% confidence interval [CI], 0.001 to 0.075; p=0.000). MO patients were more likely to present with decreased esophageal sensitivit…

medicine.medical_specialtyCross-sectional studyGastric BypassSubgroup analysisMorbidly obeseGastroenterology03 medical and health sciences0302 clinical medicineAcid refluxSensitivityInternal medicinemedicineHumansObesityEsophagusHepatologybusiness.industrypH monitoringGastroenterologyRefluxOdds ratiomedicine.diseaseConfidence intervalObesity Morbidmedicine.anatomical_structureGastroesophageal reflux030220 oncology & carcinogenesisGERD030211 gastroenterology & hepatologyOriginal ArticlebusinessGut and Liver
researchProduct

Associated factors to psychiatric morbidity in postmenopausal phases.

1998

Abstract Background: The greatest risk of psychiatric morbidity during the climacteric years is linked to a greater exposure to stressful life experiences, women's dissatisfaction with their role in society and to an absence of social backup. The question to be posed now is the extent to which the longitudinal surveys can confirm, refute or complement the results of the cross-sectional analyses. Methods: A study involving population-based cohorts was carried out on a sample of 120 women who had been previously identified as being premenopausal or menopausal during a cross-sectional examination conducted between 1987 and 1988 within the city of Valencia (Spain). The aims were to analyze the …

medicine.medical_specialtyCross-sectional studyPopulationGeneral Biochemistry Genetics and Molecular BiologyCohort StudiesLife Change EventsSocial supportConfidence IntervalsOdds RatioMedicineHumansPsychiatryeducationPsychiatric Status Rating Scaleseducation.field_of_studybusiness.industrySocial changeObstetrics and GynecologyGender IdentitySocial SupportOdds ratioMiddle AgedPostmenopauseCross-Sectional StudiesLogistic ModelsSocial ClassSpainFemalebusinessClimactericPsychosocialCohort studyFollow-Up StudiesMaturitas
researchProduct

Reference values for mean overnight saturation in sleep apnoea – the European Sleep Apnoea Database (ESADA)

2020

Introduction: Normative values for mean overnight oxygen saturation during sleep in apnoea patients stratified for age, BMI, and sleep apnoea severity are lacking. Aim: To establish reference intervals for overnight mean saturation in a large sleep apnoea patient cohort. Methods: Mean overnight oxygen saturation was analysed in adult patients (n=23,220) from the European Sleep Apnoea Database (ESADA, 30 sleep centres, 18 European countries). Data were classified according to age, gender, BMI ( Results: Mean overnight saturation was 93.0% (95% confidence interval (CI) 92.9 to 93.1%). Age influenced the adjusted mean nocturnal saturation (93.6%, 93.2%, 92.9%, 92.5%, 92.2% and 91.9% for those …

medicine.medical_specialtyDatabasebusiness.industryConfoundingcomputer.software_genreApnoea / HypopneaSleep medicineSleep in non-human animalsConfidence intervalReference valuesparasitic diseasesCohortmedicinebusinessSaturation (chemistry)computerOxygen saturation (medicine)Sleep and control of breathing
researchProduct

Global public awareness about atrial fibrillation

2017

Essentials Early recognition of atrial fibrillation helps in stroke prevention. Survey in 10 countries to assess public awareness of atrial fibrillation. Overall global awareness of atrial fibrillation was 48%. Less than 46% of participants were aware atrial fibrillation leads to stroke. Background Atrial fibrillation (AF) is an important cause of ischemic stroke that often remains undetected until stroke occurs. Awareness of the risk factors and symptoms is important so that AF can be diagnosed and thromboprophylaxis given. However, the extent of public awareness of AF is uncertain. We assessed public awareness of AF across six continents and compared it with that of other thrombotic and n…

medicine.medical_specialtyDeep veinPopulationpopulation030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicinepreventionInternal medicinePalpitationsmedicineatrial fibrillationawarenesssurvey030212 general & internal medicineeducationStrokethrombosisPublic awarenesseducation.field_of_studybusiness.industryAtrial fibrillationHematologyglobalmedicine.diseaseThrombosisConfidence intervalmedicine.anatomical_structureinternationalEmergency medicineCardiologyOriginal Articlemedicine.symptombusinessOriginal Articles: ThrombosisResearch and Practice in Thrombosis and Haemostasis
researchProduct

Time perception in depression: a meta-analysis.

2014

Background Depressive patients frequently report to perceive time as going by very slowly. Potential effects of depression on duration judgments have been investigated mostly by means of four different time perception tasks: verbal time estimation, time production, time reproduction, and duration discrimination. Ratings of the subjective flow of time have also been obtained. Methods By means of a classical random-effects meta-regression model and a robust variance estimation model, this meta-analysis aims at evaluating the inconsistent results from 16 previous studies on time perception in depression, representing data of 433 depressive patients and 485 healthy control subjects. Results Dep…

medicine.medical_specialtyDepressive DisorderTime FactorsDepressionAudiologyTime perceptionDevelopmental psychologyPsychiatry and Mental healthClinical PsychologyInterval (music)Duration (music)Meta-analysisVariance estimationTime PerceptionmedicineHumansMeta-regressionPsychologyTime discriminationDepression (differential diagnoses)Journal of affective disorders
researchProduct

Prognostic Value and Kinetics of Soluble Neprilysin in Acute Heart Failure

2015

Abstract Objectives This study sought to examine the prognostic value of the soluble form of neprilysin (sNEP) in acute heart failure (AHF) and sNEP kinetics during hospital admission. Background sNEP was recently identified in chronic heart failure (HF) and was associated with cardiovascular outcomes. Methods A total of 350 patients (53% women, mean 72.6 ± 10.7 years of age) were included in the study. Primary endpoints were composites of cardiovascular death or HF hospitalizations at short-term (2 months) and long-term (mean: 1.8 ± 1.2 years) follow-up. sNEP was measured using an ad hoc–modified enzyme-linked immunosorbent assay, and its prognostic value was assessed using Cox regression …

medicine.medical_specialtyEjection fractionProportional hazards modelbusiness.industryHazard ratioProhormonemedicine.diseaseBrain natriuretic peptideGastroenterologyConfidence intervalHeart failureInternal medicinemedicineCardiology and Cardiovascular MedicineIntensive care medicinebusinessNeprilysinmedicine.drugJACC: Heart Failure
researchProduct

Electromyographic Activity Evolution of Local Twitch Responses During Dry Needling of Latent Trigger Points in the Gastrocnemius Muscle: A Cross-Sect…

2019

Abstract Objective Trigger points (TrPs) are hypersensitive spots within taut bands of skeletal muscles that elicit referred pain and motor changes. Among the variety of techniques used for treating TrPs, dry needling is one of the most commonly applied interventions. The question of eliciting local twitch responses (LTRs) during TrP dry needling is unclear. Our main aim was to investigate the evolution of the electromyographic (EMG) peak activity of each LTR elicited during dry needling into latent TrPs of the gastrocnemius medialis muscle. Methods Twenty asymptomatic subjects with latent TrPs in the gastrocnemius medialis muscle participated in this cross-sectional study. Changes in EMG s…

medicine.medical_specialtyElectromyographyAsymptomatic03 medical and health sciencesGastrocnemius muscle0302 clinical medicineInternal medicinemedicineHumansMuscle SkeletalMyofascial Pain Syndromes030222 orthopedicsDry needlingReferred painmedicine.diagnostic_testbusiness.industryTrigger PointsGeneral MedicineConfidence intervalData at RestCross-Sectional StudiesAnesthesiology and Pain MedicineDry NeedlingCardiologyNeurology (clinical)Analysis of variancemedicine.symptombusiness030217 neurology & neurosurgeryPain Medicine
researchProduct

Real‐world evidence of the effectiveness on glycaemic control of early simultaneous versus later sequential initiation of basal insulin and glucagon‐…

2020

Abstract Aim To assess the impact of the timing of initiating both basal insulin and glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) on reaching glycaemic control targets over 6 and 12 months in people with type 2 diabetes (T2D) uncontrolled on oral antihyperglycaemic drugs with an HbA1c of 9% or higher. Methods This retrospective cohort study assessed the impact of the timing of initiating both basal insulin and GLP‐1 RA therapies on reaching glycaemic targets (HbA1c < 7% and <8%, and ≥1% and ≥2% HbA1c reduction) over 12 months in people with markedly uncontrolled T2D (HbA1c ≥ 9%) on oral antihyperglycaemic drugs identified on the Optum Humedica database (electronic medical records; …

medicine.medical_specialtyEndocrinology Diabetes and MetabolismInsulins030209 endocrinology & metabolismGlycemic ControlType 2 diabetes030204 cardiovascular system & hematologyGlucagon-Like Peptide-1 Receptor03 medical and health sciences0302 clinical medicineEndocrinologyGLP‐1 analogueInternal medicinecohort studyInternal MedicineHumansHypoglycemic AgentsInsulinMedicinebasal insulinRetrospective StudiesGlycated Hemoglobindatabase researchbusiness.industryMedical recordHazard ratioRetrospective cohort studyOriginal Articlesmedicine.diseaseGlucagon-like peptide-1Confidence intervalglycaemic controlDiabetes Mellitus Type 2Pharmaceutical PreparationsCohortOriginal Articletype 2 diabetesbusinessCohort studyDiabetes, Obesity and Metabolism
researchProduct

Long-term effectiveness of agalsidase alfa enzyme replacement in Fabry disease: A Fabry Outcome Survey analysis

2015

Outcomes from 5 years of treatment with agalsidase alfa enzyme replacement therapy (ERT) for Fabry disease in patients enrolled in the Fabry Outcome Survey (FOS) were compared with published findings for untreated patients with Fabry disease. Data were extracted from FOS, a Shire-sponsored database, for comparison with data from three published studies. Outcomes evaluated were the annualized rate of change in estimated glomerular filtration rate (eGFR) and left ventricular mass indexed to height (LVMI) as well as time to and ages at a composite morbidity endpoint and at death. FOS data were extracted for 740 treated patients who were followed for a median of ~ 5 years. Compared with no trea…

medicine.medical_specialtyEndocrinology Diabetes and MetabolismUrologyCardiomyopathyRenal functionSE Standard errorLeft ventricular hypertrophyBiochemistryLVH Left ventricular hypertrophyLong-term effectivenessEndocrinologyGeneticsMedicineMDRD Modification of Diet in Renal Diseaselcsh:QH301-705.5Molecular BiologyAgalsidase alfaeGFR Estimated glomerular filtration rateFabry diseaselcsh:R5-920CI Confidence intervalbusiness.industryEnzyme replacement therapymedicine.diseaseEgfr Estimated glomerular filtration rateFabry diseaseSurgeryARB Angiotensin receptor blockerSEM Standard error of the meanStandard errorlcsh:Biology (General)SI:TherapyEnzyme replacement therapyCohortFOS Fabry Outcome SurveyLVMI Left ventricular mass indexed to heightlcsh:Medicine (General)businessACEI Angiotensin-converting enzyme inhibitorAgalsidase alfaERT Enzyme replacement therapyMolecular Genetics and Metabolism Reports
researchProduct